Covid Vaccinations Identified as Potential Triggers for Cardiac Arrests in Major Research
In a recent study led by Dr. Rolf Schreckenberg and his team from Justus-Liebig University Gießen and Hannover Medical School, the behaviour of spike proteins produced by mRNA vaccines has been under scrutiny. The researchers transfected human cardiomyocytes (heart muscle cells) and other human cell lines with Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273.
The study's findings suggest that spike protein aggregation inside heart cells could be a contributing factor to deadly post-vaccination heart issues like myocarditis. While the S1 subunit of the spike protein, the key piece that stimulates the immune response, was able to escape the cells and move into the surrounding environment, the other spike protein components, including the sticky aggregates, remained trapped inside the heart cells.
The spike protein aggregates in human heart cells followed specific patterns, depending on the cell type. The intracellular aggregation of spike protein subunits in heart cells plays a key role in the development of myocarditis and other related inflammatory cardiac events following vaccination.
However, it is crucial to note that there is no credible evidence directly linking Covid mRNA vaccines to cardiac arrests caused by spike protein aggregation in heart cells. The available research recognizes myocarditis and pericarditis as rare but notable adverse events following mRNA COVID-19 vaccination, particularly in young males shortly after vaccination.
The US FDA has updated safety labeling for mRNA COVID-19 vaccines to warn about myocarditis and pericarditis, with an incidence estimated around 27 cases per million males aged 12 to 24 years after the latest vaccine formulas. Most patients presented with chest pain within a few days of vaccination, and cardiac MRI often showed markers of myocardial injury.
Despite these cases, there is no indication that spike protein aggregation in heart cells is a mechanism involved. Population-wide studies, including a nationwide cohort of over 1.5 million individuals, have not shown increased risk for cardiac arrest or other severe cardiovascular adverse events after updated mRNA vaccines.
The findings of this study add to the growing body of research questioning the long-term effects of spike protein production and its potential impact on human health. The need for more research into the long-term effects of these vaccines, particularly as more data emerges about their impact on different age groups and underlying health conditions, remains critical.
In summary, while myocarditis/pericarditis are recognized and very rare adverse effects related to mRNA COVID-19 vaccines, there is no substantiated scientific evidence that spike protein aggregation in heart cells occurs post-vaccination or that it causes cardiac arrests. Current evidence from large-scale, rigorous studies supports the cardiovascular safety of mRNA vaccines and highlights the far greater risk of cardiac complications from actual COVID-19 infection.
References: [1] [2] [3] [4] [5]
- The study's findings suggest that spike protein aggregation inside heart cells, a pattern observed in different human cell types, could potentially be related to the development of myocarditis and other inflammatory cardiac events following vaccination against medical-conditions like COVID-19.
- Despite cases of myocarditis and pericarditis being recognized as rare adverse events following mRNA COVID-19 vaccination, particularly in young males shortly after vaccination, there is no substantiated scientific evidence that spike protein aggregation in heart cells happens post-vaccination or causes cardiac arrests.
- The need for extensive research into the long-term effects of mRNA vaccines on health-and-wellness, particularly on various age groups and underlying health-conditions, is critical given the growing body of research questioning the long-term impacts of spike protein production on human health.
